Microenvironmental regulation of stem cells in intestinal homeostasis and cancer

Nature

Volumn 474, Issue 7351, 2011, Pages 318-326

  Medema, Jan Paul ^a   Vermeulen, Louis ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CELL ORGANELLE; DEVELOPMENTAL BIOLOGY; FUNCTIONAL MORPHOLOGY; HOMEOSTASIS; IDENTIFICATION METHOD;

ADENOMA; ANTIGEN PRESENTING CELL; CANCER STEM CELL; CARCINOMA; CELL DIFFERENTIATION; CELL FATE; CELLULAR DISTRIBUTION; COLORECTAL CANCER; EPITHELIUM; GENE MUTATION; HOMEOSTASIS; HUMAN; INTESTINAL HOMEOSTASIS; INTESTINE CANCER; INTESTINE CRYPT; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL;

ANIMALS; HOMEOSTASIS; HUMANS; INTESTINAL NEOPLASMS; INTESTINES; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; STEM CELLS; TUMOR MICROENVIRONMENT;

EID: 79959238013     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature10212     Document Type: Review

References (100)

1. Heath, J. P. Epithelial cell migration in the intestine. Cell Biol. Int. 20, 139-146 (1996). (Pubitemid 26132259)
2. Ferlay, J. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893-2917 (2010).
3. Vermeulen, L., Sprick, M. R., Kemper, K., Stassi, G. & Medema, J. P. Cancer stem cells-old concepts, new insights. Cell Death Differ. 15, 947-958 (2008). (Pubitemid 351712600)
4. Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759-767 (1990).
5. Vermeulen, L. et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nature Cell Biol. 12, 468-476 (2010).
6. Barker, N. et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003-1007 (2007). (Pubitemid 350014593)
7. Breault, D. T. et al. Generation of mTert-GFP mice as a model to identify and study tissue progenitor cells. Proc. Natl Acad. Sci. USA 105, 10420-10425 (2008).
8. Montgomery, R. K. et al. Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Proc. Natl Acad. Sci. USA 108, 179-184 (2011).
9. Sangiorgi, E. & Capecchi, M. R. Bmi1 is expressed in vivo in intestinal stem cells. Nature Genet. 40, 915-920 (2008). (Pubitemid 351913652)
10. Zhu, L. et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457, 603-607 (2009).
11. Cheng, H. & Leblond, C. P. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am. J. Anat. 141, 537-561 (1974).
12. Lopez-Garcia, C., Klein, A. M., Simons, B. D. & Winton, D. J. Intestinal stem cell replacement follows a pattern of neutral drift. Science 330, 822-825 (2010).
13. Snippert, H. J. et al. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 143, 134-144 (2010).
14. Crosnier, C., Stamataki, D. & Lewis, J. Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nature Rev. Genet. 7, 349-359 (2006).
15. Hardwick, J. C., Kodach, L. L., Offerhaus, G. J. & van den Brink, G. R. Bone morphogenetic protein signalling in colorectal cancer. Nature Rev. Cancer 8, 806-812 (2008).
16. Reya, T. & Clevers, H. Wnt signalling in stem cells and cancer. Nature 434, 843-850 (2005). (Pubitemid 40558990)
17. Kim, K. A. et al. Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science 309, 1256-1259 (2005).
18. Pinto, D., Gregorieff, A., Begthel, H., & Clevers, H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev. 17, 1709-1713 (2003). (Pubitemid 36870334)
19. Korinek, V. et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nature Genet. 19, 379-383 (1998). (Pubitemid 28357912)
20. Gregorieff, A. et al. Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 129, 626-638 (2005). (Pubitemid 41096648)
21. van de Wetering, M. et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241-250 (2002).
22. Sato, T. et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469, 415-418 (2010).
23. Fre, S. et al. Notch signals control the fate of immature progenitor cells in the intestine. Nature 435, 964-968 (2005). (Pubitemid 40896323)
24. van Es, J. H. et al. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 435, 959-963 (2005).
25. van Es, J. H., de Geest, N., van de Born, M., Clevers, H. & Hassan, B. A. Intestinal stem cells lacking the Math1 tumour suppressor are refractory to Notch inhibitors. Nature Commun. 1, 18 (2010).
26. He, X. C. et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signaling. Nature Genet. 36, 1117-1121 (2004). (Pubitemid 41184475)
27. Haramis, A. P. et al. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 303, 1684-1686 (2004).
28. Auclair, B. A., Benoit, Y. D., Rivard, N., Mishina, Y. & Perreault, N. Bone morphogenetic protein signaling is essential for terminal differentiation of the intestinal secretory cell lineage. Gastroenterology 133, 887-896 (2007). (Pubitemid 47374143)
29. Bijlsma, M. F., Spek, C. A. & Peppelenbosch, M. P. Hedgehog: an unusual signal transducer. Bioessays 26, 387-394 (2004). (Pubitemid 38461619)
30. van Dop, W. A. et al. Depletion of the colonic epithelial precursor cell compartment upon conditional activation of the Hedgehog pathway. Gastroenterology 136, 2195-2203 (2009).
31. van den Brink, G. R. et al. Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation. Nature Genet. 36, 277-282 (2004).
32. van Dop, W. A. et al. Loss of Indian Hedgehog activates multiple aspects of a wound healing response in the mouse intestine. Gastroenterology 139, 1665-1676 (2010).
33. Varnat, F., Zacchetti, G. & Altaba, A. Hedgehog pathway activity is required for the lethality and intestinal phenotypes of mice with hyperactive Wnt signaling. Mech. Dev. 127, 73-81 (2010).
34. Ootani, A. et al. Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche. Nature Med. 15, 701-706 (2009).
35. Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262-265 (2009).
36. Cunningham, D. et al. Colorectal cancer. Lancet 375, 1030-1047 (2010).
37. Tenesa, A. et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nature Genet. 40, 631-637 (2008). (Pubitemid 351601219)
38. Tomlinson, I. P. et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nature Genet. 40, 623-630 (2008). (Pubitemid 351601204)
39. Markowitz, S. D. & Bertagnolli, M. M. Molecular origins of cancer: molecular basis of colorectal cancer. N. Engl. J. Med. 361, 2449-2460 (2009).
40. Goss, K. H. & Groden, J. Biology of the adenomatous polyposis coli tumor suppressor. J. Clin. Oncol. 18, 1967-1979 (2000). (Pubitemid 30261936)
41. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
42. Moser, A. R., Pitot, H. C. & Dove, W. F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324 (1990).
43. Barker, N. et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608-611 (2009).
44. Huntly, B. J. et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6, 587-596 (2004). (Pubitemid 40017702)
45. Shen, M. M., Wang, X., Economides, K. D., Walker, D. & Abate-Shen, C. Progenitor cells for the prostate epithelium: roles in development, regeneration, and cancer. Cold Spring Harb. Symp. Quant. Biol. 73, 529-538 (2008).
46. Holland, E. C. et al. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nature Genet. 25, 55-57 (2000). (Pubitemid 30257036)
47. Visvader, J. E. Cells of origin in cancer. Nature 469, 314-322 (2011).
48. Takayama, T. et al. Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness. Clin. Gastroenterol. Hepatol. 3, S42-S45 (2005). (Pubitemid 40977879)
49. Novelli, M. R. et al. Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science 272, 1187-1190 (1996). (Pubitemid 26169475)
50. Albuquerque, C. et al. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the β-catenin signaling cascade. Hum. Mol. Genet. 11, 1549-1560 (2002). (Pubitemid 34679255)
51. Crabtree, M. et al. Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients. Oncogene 22, 4257-4265 (2003). (Pubitemid 36876246)
52. Rubinfeld, B., Albert, I., Porfiri, E., Munemitsu, S. & Polakis, P. Loss of β-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res. 57, 4624-4630 (1997). (Pubitemid 27441070)
53. Tanaka, T. et al. Dextran sodium sulfate strongly promotes colorectal carcinogenesis in ApcMin/+ mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms. Int. J. Cancer 118, 25-34 (2006). (Pubitemid 41681577)
54. Su, L. K. et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668-670 (1992).
55. Taketo, M. M. & Edelmann, W. Mouse models of colon cancer. Gastroenterology 136, 780-798 (2009).
56. Aoki, K., Tamai, Y., Horiike, S., Oshima, M. & Taketo, M. M. Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Δ716 Cdx2+/compound mutant mice. Nature Genet. 35, 323-330 (2003). (Pubitemid 37486915)
57. Janssen, K. P. et al. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Gastroenterology 131, 1096-1109 (2006).
58. Luo, F. et al. Mutated K-rasAsp12 promotes tumourigenesis in ApcMin mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways. Int. J. Exp. Pathol. 90, 558-574 (2009).
59. Marsh, V. et al. Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation. Nature Genet. 40, 1436-1444 (2008).
60. Gould, K. A. et al. Genetic evaluation of candidate genes for the Mom1 modifier of intestinal neoplasia in mice. Genetics 144, 1777-1785 (1996). (Pubitemid 26427924)
61. 2 gene. J. Biol. Chem. 275, 34013-34016 (2000).
62. Takaku, K. et al. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92, 645-656 (1998). (Pubitemid 28141513)
63. Kitamura, T. et al. SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion. Nature Genet. 39, 467-475 (2007). (Pubitemid 46514777)
64. Kodach, L. L. et al. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers. Gastroenterology 134, 1332-1341 (2008).
65. Kim, B. G. et al. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 441, 1015-1019 (2006).
66. Katajisto, P. et al. LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis. Nature Genet. 40, 455-459 (2008). (Pubitemid 351450888)
67. Itzkowitz, S. H. & Yio, X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol Gastrointest. Liver Physiol. 287, G7-G17 (2004). (Pubitemid 38802113)
68. Chan, A. T., Ogino, S. & Fuchs, C. S. Aspirin use and survival after diagnosis of colorectal cancer. J. Am. Med. Assoc. 302, 649-658 (2009).
69. Oshima, M. et al. Suppression of intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803-809 (1996). (Pubitemid 26404280)
70. Shao, J., Sheng, G. G., Mifflin, R. C., Powell, D. W. & Sheng, H. Roles of myofibroblasts in prostaglandin E2-stimulated intestinal epithelial proliferation and angiogenesis. Cancer Res. 66, 846-855 (2006). (Pubitemid 43165950)
71. Gounaris, E. et al. Mast cells are an essential hematopoietic component for polyp development. Proc. Natl. Acad. Sci. USA 104, 19977-19982 (2007).
72. Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883-899 (2010).
73. Greten, F. R. et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285-296 (2004). (Pubitemid 39061110)
74. Lee, S. H. et al. ERK activation drives intestinal tumorigenesis in Apcmin/+ mice. Nature Med. 16, 665-670 (2010).
75. Wood, L. D. et al. The genomic landscapes of human breast and colorectal cancers. Science 318, 1108-1113 (2007). (Pubitemid 350134889)
76. Sottoriva, A. et al. Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity. Cancer Res. 70, 46-56 (2010).
77. Clarke, M. F. et al. Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 66, 9339-9344 (2006). (Pubitemid 44623625)
78. Todaro, M. et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1, 389-402 (2007). (Pubitemid 47506537)
79. de Sousa, E. M., Vermeulen, L., Richel, D. J. & Medema, J. P. Targeting Wnt signaling in colon cancer stem cells. Clin. Cancer Res. 17, 647-653 (2010).
80. Todaro, M., Francipane, M. G., Medema, J. P. & Stassi, G. Colon cancer stem cells: promise of targeted therapy. Gastroenterology 138, 2151-2162 (2010).
81. Dalerba, P. et al. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl Acad. Sci. USA 104, 10158-10163 (2007). (Pubitemid 47175279)
82. O'Brien, C. A., Pollett, A., Gallinger, S. & Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110 (2007). (Pubitemid 46067310)
83. Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111-115 (2007). (Pubitemid 46067311)
84. Vermeulen, L. et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc. Natl Acad. Sci. USA 105, 13427-13432 (2008).
85. Kemper, K. et al. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res. 70, 719-729 (2010).
86. Borovski, T., Vermeulen, L., Sprick, M. R. & Medema, J. P. One renegade cancer stem cell? Cell Cycle 8, 803-808 (2009).
87. Zucchi, I. et al. The properties of a mammary gland cancer stem cell. Proc. Natl Acad. Sci. USA 104, 10476-10481 (2007). (Pubitemid 47185690)
88. Fodde, R. & Brabletz, T. Wnt/β-catenin signaling in cancer stemness and malignant behavior. Curr. Opin. Cell Biol. 19, 150-158 (2007). (Pubitemid 46386404)
89. Hoey, T. et al. DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell 5, 168-177 (2009).
90. Lombardo, Y. et al. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology 140, 297-309 (2011).
91. Varnat, F., Siegl-Cachedenier, I., Malerba, M., Gervaz, P. & Altaba, A. Loss of WNT-TCF addiction and enhancement of HH-GLI1 signalling define the metastatic transition of human colon carcinomas. EMBO Mol. Med. 2, 440-457 (2010).
92. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008). (Pubitemid 351636299)
93. Potten, C S., Gandara, R., Mahida, Y. R., Loeffler, M. & Wright, N. A. The stem cells of small intestinal crypts: where are they? Cell Prolif. 42, 731-750 (2009).
94. van der Flier, L. G. et al. Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell 136, 903-912 (2009).
95. Schepers, A. G., Vries, R., van den, B. M., van de, W. M. & Clevers, H. Lgr5 intestinal stem cells have high telomerase activity and randomly segregate their chromosomes. EMBO J. 30, 1104-1109 (2011).
96. Ponder, B. A. et al. Derivation of mouse intestinal crypts from single progenitor cells. Nature 313, 689-691 (1985). (Pubitemid 15172476)
97. Loeffler, M., Birke, A., Winton, D. & Potten, C. Somatic mutation, monoclonality and stochastic models of stem cell organization in the intestinal crypt. J. Theor. Biol. 160, 471-491 (1993).
98. Huang, E. H. et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 69, 3382-3389 (2009).
99. Campbell, F. et al. Post-irradiation somatic mutation and clonal stabilisation time in the human colon. Gut 39, 569-573 (1996). (Pubitemid 26376041)
100. Trumpp, A., Essers, M. & Wilson, A. Awakening dormant haematopoietic stem cells. Nature Rev. Immunol. 10, 201-209 (2010).